Industry Session
.png)
Rachel Minrovic (she/her/hers)
Senior Formulation Engineer (R&D)
Oakwood Labs
Oakwood's Chroniject technology provides a tunable long-acting injectable platform for a wide array of molecules and applications. Efficacious release profiles have been generated from as fast as two days to as long as one year.
Oakwood's Chroniject technology provides the platform for scale-up of the formulation process, allowing for the critical quality attributes of the long-acting injectable formulations to be maintained from initial feasibility batch sizes in the gram-scale to clinical and commercial batch sizes in the kilogram-scale.